| [1]Emberton M, Marberger M, de la Rosette J.Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey[J].Int J Clin Pract,2008,62(1):18-26[2]刘平, 黄伟佳, 汪中扬, 等.前列腺增生症尿动力学检查的临床研究[J].岭南现代临床外科,2002,2(2):44-45[3]Schwinn DA, Michelotti GA.alpha1-adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha1d subtype in filling symptoms and effects of ageing on vascular expression[J].BJU Int,2000,85(Suppl 2):6-11[4]Narayan P, Lepor H.Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia[J].Urology,2001,57(3):466-70[5]Matsumoto S, Uemura H.Examination of the mechanism of ameliorating effect of alpha 1-blocker on storage symptoms associated with benign prostatic hyperplasia[J].Hinyokika Kiyo,2008,54(6):453-456[6]Chapple CR, Roehrborn CG.A shifted paradigm for the further understanding Evaluation and treatment of lower urinary tract symptoms in men: focus on the bladder[J].Eur Urol,2006,49(4):651-659[7]Yoshida A, Kageyama A, Fujino T, et al.Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis[J].Urology,2010,76(4):1017-[8]文建国, 陈燕, 李金升, 等.索利那新治疗膀胱过度活动症对逼尿肌功能的影响[J].中华泌尿外科杂志,2011,32(8):532-534 |
